These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 18645360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury.
    Suyama H, Kawasaki Y, Morikawa S, Kaneko K, Yamanoue T.
    Hiroshima J Med Sci; 2008 Dec; 57(3-4):79-84. PubMed ID: 19260559
    [Abstract] [Full Text] [Related]

  • 3. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y.
    ASAIO J; 2007 Dec; 53(3):324-8. PubMed ID: 17515723
    [Abstract] [Full Text] [Related]

  • 4. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
    Tsushima K, Kubo K, Yoshikawa S, Koizumi T, Yasuo M, Furuya S, Hora K.
    Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
    [Abstract] [Full Text] [Related]

  • 5. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
    Nakamura T, Fujiwara N, Sato E, Kawagoe Y, Ueda Y, Yamada S, Koide H.
    ASAIO J; 2009 Apr; 55(4):395-9. PubMed ID: 19506468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S.
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [Abstract] [Full Text] [Related]

  • 8. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
    Sakamoto Y, Mashiko K, Obata T, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y.
    ASAIO J; 2007 Feb; 53(5):646-50. PubMed ID: 17885340
    [Abstract] [Full Text] [Related]

  • 9. Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism.
    Kushi H, Miki T, Sakagami Y, Saito T, Tanjoh K.
    Ther Apher Dial; 2008 Aug; 12(4):292-7. PubMed ID: 18789116
    [Abstract] [Full Text] [Related]

  • 10. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C, Hara Y, Kuriyama N, Nakamura T, Nishida O.
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [Abstract] [Full Text] [Related]

  • 11. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
    Tojimbara T, Sato S, Nakajima I, Fuchinoue S, Akiba T, Teraoka S.
    Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
    [Abstract] [Full Text] [Related]

  • 12. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T, Shinozaki M, Akizawa T, Shima Y, Takaesu H, Nasu H.
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [Abstract] [Full Text] [Related]

  • 13. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K.
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [Abstract] [Full Text] [Related]

  • 14. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y, Obata T, Okamoto Y, Iwai K, Saito K, Yokoyama K, Takinami M, Tanifuji Y.
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [Abstract] [Full Text] [Related]

  • 15. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation.
    Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K.
    Crit Care; 2005 Oct; 9(6):R653-61. PubMed ID: 16280061
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
    Ebihara I, Hirayama K, Kaneko S, Nagai M, Ogawa Y, Fujita S, Usui J, Mase K, Yamagata K, Kobayashi M.
    Ther Apher Dial; 2008 Aug; 12(4):285-91. PubMed ID: 18789115
    [Abstract] [Full Text] [Related]

  • 18. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
    Ebihara I, Hirayama K, Nagai M, Shiina E, Koda M, Gunji M, Okubo Y, Sato C, Usui J, Yamagata K, Kobayashi M.
    Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
    [Abstract] [Full Text] [Related]

  • 19. Early hemoperfusion with a polymyxin b column improves gastric intramucosal pH in sepsis.
    Kushi H, Miki T, Sakagami Y, Sato J, Saito T, Tanjoh K.
    Ther Apher Dial; 2008 Aug; 12(4):278-84. PubMed ID: 18789114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.